Recombinate Health Co-Invest I, LLC 2026: Is It Legit? Form D Raise, Investors, Who Is Behind It

Q: What is Recombinate Health Co-Invest I, LLC?

Recombinate Health Co-Invest I, LLC is an issuer that filed a Form D with the SEC on November 4, 2026. The filing claims 506(b), 3(c)(1).

Q: Is Recombinate Health Co-Invest I, LLC legit?

AltStreet does not rate legitimacy; it reports the public record. Recombinate Health Co-Invest I, LLC filed a Form D with the SEC on November 4, 2026 claiming 506(b), 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $2,910,000 sold to 26 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Q: Is Recombinate Health Co-Invest I, LLC registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Recombinate Health Co-Invest I, LLC claimed 506(b), 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

Q: How much has Recombinate Health Co-Invest I, LLC raised?

Recombinate Health Co-Invest I, LLC reported $2,910,000 sold from 26 investors as of the Form D filed November 4, 2026.

Q: Who is selling Recombinate Health Co-Invest I, LLC and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.

Q: Where is Recombinate Health Co-Invest I, LLC located?

The issuer's address on its SEC filings is 15 Onondaga Ave., #12355, San Francisco, CA 94112. Its phone number of record is (865) 384-5174. It is organized under the laws of Delaware.

AltStreetEDGAR DatabaseRecombinate Health Co-Invest I, LLC
SEC filing record
Primary Source · SEC.gov
Recombinate Health Co-Invest I, LLCCo-Investment Vehicle2026 vintage506(b), 3(c)(1)
Raised
$3M
Investors
26
Min Invest
None stated
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
Claim freeVerify, $480/yr
AltStreet Analysis
·Generated from EDGAR primary sources
Recombinate Health Co-Invest I, LLC is a Delaware-formed pooled investment fund that filed a Form D on 2026-11-04 under the 506(b) exemption combined with the 3(c)(1) exclusion, raising $2.9M from 26 investors. The filing was submitted by related parties Recombinate Health LLC (Director) and executives/promoters Matthew Hollingsworth and Matthew Survis; minimum investment and first sale date were not disclosed on the filing, and no parent platform has been matched.
This is a small co-investment vehicle structured as a 3(c)(1) pooled fund relying on 506(b), a common combination for privately-placed alternative investment SPVs with fewer than 100 beneficial owners. At $2.9M raised across 26 investors (average check ~$112K), the raise size and investor count fall within the typical range for early-stage or niche co-invest vehicles, though the minimum investment tier cannot be assessed since that field was left blank on the filing.
Data Flags
First Sale DateFirst sale date is not disclosed despite a total raise well under $100M, which is the threshold where this omission is typically expected for large institutional filings; for a $2.9M raise, the missing first sale date is a minor data gap worth noting.
ExemptionFiling claims both 506(b) and 3(c)(1) simultaneously, a standard combination for privately offered pooled investment funds relying on the Investment Company Act exclusion alongside the Securities Act exemption.
EDGAR Filing Data
Form D — Primary Source
View on SEC.gov 
CIK Number0002160709
Entity NameRecombinate Health Co-Invest I, LLC
Exemption506(b), 3(c)(1)
Entity Type—
Jurisdiction of OrganizationDelaware
Issuer Address15 Onondaga Ave., #12355, San Francisco, CA 94112
Phone(865) 384-5174
Industry / Fund Type—
Securities TypePooled Investment Fund
First Sale Date—
Filing DateNovember 4, 2026
Accession Number0002160709-26-000001
Total Offering Amount—
Total Amount Sold$2,910,000
Total Investors26
Minimum Investment$0 (no stated minimum)
Offering Duration—
State (Issuer Address)CA
Amendment CountOriginal filing only
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
n/a Recombinate Health LLC
Director · San Francisco, CA
Matthew Hollingsworth
Executive Officer, Promoter · San Francisco, CA
Matthew Survis
Executive Officer, Promoter · San Francisco, CA
Questions About Recombinate Health Co-Invest I, LLC
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Recombinate Health Co-Invest I, LLC?Recombinate Health Co-Invest I, LLC is an issuer that filed a Form D with the SEC on November 4, 2026. The filing claims 506(b), 3(c)(1).
Is Recombinate Health Co-Invest I, LLC legit?AltStreet does not rate legitimacy; it reports the public record. Recombinate Health Co-Invest I, LLC filed a Form D with the SEC on November 4, 2026 claiming 506(b), 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $2,910,000 sold to 26 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Recombinate Health Co-Invest I, LLC registered with or approved by the SEC?No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Recombinate Health Co-Invest I, LLC claimed 506(b), 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Recombinate Health Co-Invest I, LLC raised?Recombinate Health Co-Invest I, LLC reported $2,910,000 sold from 26 investors as of the Form D filed November 4, 2026.
Who is selling Recombinate Health Co-Invest I, LLC and how are they paid?The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.
Where is Recombinate Health Co-Invest I, LLC located?The issuer's address on its SEC filings is 15 Onondaga Ave., #12355, San Francisco, CA 94112. Its phone number of record is (865) 384-5174. It is organized under the laws of Delaware.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Claim this profile, freeVerify this entity, $480/yr
Sponsor EDGAR Footprint
Entities on EDGAR2
Total raised$17M
Total investors33
Vintages2026
Aggregated across this manager's Form D entities tracked by AltStreet. Source: SEC EDGAR.
Related Entities
Tended Investors, LLC
2026 · Single-DealSame manager
$14M
Also filed in November 2026
Dawson Portfolio Finance 7 LP
$4.9BVALOR EQUITY PARTNERS VII-B L.P.
$3.3BVALOR EQUITY PARTNERS VII L.P.
$3.3BVALOR EQUITY PARTNERS VII-A L.P.
$3.3BPrime Property Fund Asia Limited Partnership
$2.7BFortress Net Lease REIT
$2.4BNB Secondary Opportunities Fund VI LP
$1.9BNB Secondary Opportunities Offshore Fund VI LP
$1.5BDawson Portfolio Finance (Offshore) 7 LP
$950MGlobal Infrastructure Partners Transition Fund-C2, SCSp
$912MGlobal Infrastructure Partners Transition Fund-A/B, L.P.
$912MGlobal Infrastructure Partners Transition Fund-C, L.P.
$912M
Also filed in November 2026
Dawson Portfolio Finance 7 LP34 investors
$4.9BVOLEON INSTITUTIONAL STRATEGIES FUND LP270 investors
$4.8BBain Capital Senior Loan Fund, L.P.303 investors
$3.3BVALOR EQUITY PARTNERS VII L.P.1,476 investors
$3.3BVALOR EQUITY PARTNERS VII-B L.P.278 investors
$3.3BVALOR EQUITY PARTNERS VII-A L.P.1 investors
$3.3BCortland Growth & Income, L.P.59 investors
$3.3BVoleon Composition International Fund, Ltd.165 investors
$2.9BPrime Property Fund Asia Limited Partnership57 investors
$2.7BGLASfunds, LP4,061 investors
$2.7BVoleon Composition Domestic Fund, LP181 investors
$2.6BFortress Net Lease REIT9,186 investors
$2.4B
All unclassified issuers →Filed in November 2026 →
EDGAR Links
All FilingsEDGAR Full Text SearchSEC Submissions API
Understand This Filing
How Form D private placements workAccredited investor requirementsSingle-layer SPV structuresAlternative-investment glossary
AltStreet Pro
Compare across asset classes
Pro subscribers access the Intelligence Terminal - normalized comparison of 100+ platforms across every alternative asset class.
Terminal plans from $149/month 
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.